Choose Your News
Loading...
The U.S. Food and Drug Administration on Monday cleared Pear Therapeutics' mobile application to help increase retention of patients undergoing outpatient treatment for opioid abuse. [Read More]
Thumbnail
Dec 10, 2018--Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that the U.S. Food and... [Read More]
Thumbnail
Dec 10, 2018--Cerus Corporation (Nasdaq:CERS) announced today that the American Red Cross has received approval by the U.S. Food and Drug Administration (FDA) for their... [Read More]
Thumbnail
BURLINGTON, Mass. & OXFORD, England -- --Dec 10, 2018--Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that the U.S. Food and Drug Administration... [Read More]
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with Avastin and chemotherapy was approved by the U.S. Food and... [Read More]
Thumbnail
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration... [Read More]
22nd Century Group Inc. has entered the Food and Drug Administration regulatory gauntlet for its very-low nicotine traditional cigarettes, the company said Wednesday. [Read More]
Alembic Pharmaceuticals on Tuesday announced that its wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration for its... [Read More]
Thumbnail
Dec 4, 2018--Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company focused on the design, development and commercialization of rechargeable implantable Sacral Neuromodulation ("SNM") solutions... [Read More]
Preview